{"id":"W1440956116","doi":"10.1182/blood.v122.21.371.371","title":"A Phase III Study Of Enzastaurin In Patients With High-Risk Diffuse Large B Cell Lymphoma Following Response To Primary Treatment: The Prelude Trial","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Clinical endpoint; Diffuse large B-cell lymphoma; Rituximab; International Prognostic Index; Prednisone; Vincristine; Placebo; Surrogate endpoint; Phases of clinical research; Oncology; Cyclophosphamide; Lymphoma; Surgery; Clinical trial; Chemotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00183717,0.0009622762,0.002212586,0.000262494,0.0002972486,0.001005778,0.0007765956,0.0009586064,0.002860103],"category_scores_gemma":[0.001021015,0.0003679847,0.001312564,0.0002184657,0.0007198375,0.0006014976,0.0004400753,0.002157312,0.0005981786],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004680072,"about_ca_system_score_gemma":0.0006319372,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004032433,"about_ca_topic_score_gemma":0.001018089,"domain_scores_codex":[0.9993813,0.000407185,0.00002355306,0.00009091749,0.00003581699,0.00006117133],"domain_scores_gemma":[0.9993083,0.0001579855,0.000144229,0.00007037988,0.00005287361,0.00026617],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9335579,0.01326895,0.003867888,0.0006753859,0.001708648,0.0001338592,0.00009524554,0.0007442208,0.009058937,0.0001978054,0.001420524,0.03527063],"study_design_scores_gemma":[0.8375269,0.1507333,0.00696088,0.00003481402,0.000665181,0.0001447801,0.00003216656,0.0005632063,0.001189454,0.000172205,0.001958405,0.00001879479],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9883857,0.006443823,0.0005025045,0.0004684848,0.0001791955,0.001410891,0.0006525895,0.0000739872,0.001882945],"genre_scores_gemma":[0.992305,0.001840321,0.0008851868,0.0006528085,0.0001999467,0.001455166,0.0009362178,0.00001337182,0.001711892],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002860103,"threshold_uncertainty_score":0.009715974,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007121130264520015,"score_gpt":0.2356998229856789,"score_spread":0.2285786927211589,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}